Photo of Pirjo Laakkonen
  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

1990 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 318 Medical biotechnology
  • Tumor biology
  • Tumor targeting
  • Phage display
  • Metastasis
  • Invasion
  • 118 Biological sciences

International and National Collaboration Publications and projects within past five years.

Publications

ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

Barok, M., Le Joncour, V., Martins, A., Isola, J., Salmikangas, M., Laakkonen, P. & Joensuu, H., 2020, In : Cancer Letters. 473, p. 156-163 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

Ramanathan, J. T., Lehtipuro, S., Sihto, H., Tovari, J., Reiniger, L., Teglasi, V., Moldvay, J., Nykter, M., Haapasalo, H., Le Joncour, V. & Laakkonen, P., 11 May 2020, In : Journal of Cellular and Molecular Medicine. 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Anagrelide for Gastrointestinal Stromal Tumor

Pulkka, O-P., Gebreyohannes, Y. K., Wozniak, A., Mpindi, J-P., Tynninen, O., Icay, K., Cervera, A., Keskitalo, S., Murumägi, A., Kulesskiy, E., Laaksonen, M., Wennerberg, K., Varjosalo, M., Laakkonen, P., Lehtonen, R., Hautaniemi, S., Kallioniemi, O., Schöffski, P., Sihto, H. & Joensuu, H., 1 Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1676-1687 12 p.

Research output: Contribution to journalArticleScientificpeer-review

A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Le Joncour, V., Martins, A., Puhka, M., Isola, J., Salmikangas, M., Laakkonen, P., Joensuu, H. & Barok, M., Oct 2019, In : Molecular Cancer Therapeutics. 18, 10, p. 1721-1730 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Activities

Finnish Brain Tumor Research Association Annual Meeting: FiBTRA 2019

Pirjo Laakkonen (Member of organizing committee), Vadim Le Joncour (Member of organizing committee), Pauliina Filppu (Member of organizing committee)
31 Oct 20191 Nov 2019

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

File

Alize Yilmazlar

Pirjo Laakkonen (Host)
Jun 2018Aug 2018

Activity: Hosting a visitor typesAcademic visit at UH

Ali Yurtseven

Pirjo Laakkonen (Host)
Jun 2018Sep 2018

Activity: Hosting a visitor typesAcademic visit at UH

Ana Martins

Pirjo Laakkonen (Host)
Jan 2018Dec 2018

Activity: Hosting a visitor typesAcademic visit at UH

Finnish Brain Tumor Research Association Annual Meeting

Vadim Le Joncour (Member of organizing committee), Pirjo Maarit Laakkonen (Member of organizing committee), Pauliina Irmeli Filppu (Attendee), Jayendrakishore Tanjore Ramanathan (Attendee), Abiodun Olanrewaju Ayo (Attendee), Seppo Ylä-Hertttuala (Speaker: Keynote), Jukka Westermarck (Member of organizing committee)
1 Nov 20162 Nov 2016

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Press / Media

Nanomedicine: Making Drugs more Precise

Pirjo Laakkonen

01/09/2017

1 Media contribution

Press/Media: Press / Media